Among patients with SLE (N=36), PF4FE correlated significantly with all conventional disease activity parameters including SLEDAI, renal SLEDAI, PGA, complement C3, C4 and anti-dsDNA, while hemopexinFE did not correlate with any of disease activity parameters, as shown in Figure 4. Here, C3 is linked to systemic lupus erythematosus.